ARTICLE: Myocardial ultrastructure of human heart failure with preserved ejection fraction
AUTHORS: Mariam Meddeb, Navid Koleini, Aleksandra Binek, Mohammad Keykhaei, Reyhane Darehgazani, Seoyoung Kwon, Celia Aboaf, Kenneth B. Margulies, Ken C. Bedi Jr, Mohamed Lehar, Kavita Sharma, Virginia S. Hahn, Jennifer E. Van Eyk, Cinthia I. Drachenberg & David A. Kass
JOURNAL: Nature Cardiovascular Research. 2024 July 25
Abstract
Over half of patients with heart failure have a preserved ejection fraction (>50%, called HFpEF), a syndrome with substantial morbidity/mortality and few effective therapies1. Its dominant comorbidity is now obesity, which worsens disease and prognosis1,2,3. Myocardial data from patients with morbid obesity and HFpEF show depressed myocyte calcium-stimulated tension4 and disrupted gene expression of mitochondrial and lipid metabolic pathways5,6, abnormalities shared by human HF with a reduced EF but less so in HFpEF without severe obesity. The impact of severe obesity on human HFpEF myocardial ultrastructure remains unexplored. Here we assessed the myocardial ultrastructure in septal biopsies from patients with HFpEF using transmission electron microscopy. We observed sarcomere disruption and sarcolysis, mitochondrial swelling with cristae separation and dissolution and lipid droplet accumulation that was more prominent in the most obese patients with HFpEF and not dependent on comorbid diabetes. Myocardial proteomics revealed associated reduction in fatty acid uptake, processing and oxidation and mitochondrial respiration proteins, particularly in very obese patients with HFpEF.
For the full article, click here.
